Urokinase and its receptor: marker of malignancy?
Gaffney
P J
PJ
Division of Haematology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK.
Cooke
D A
DA
Burnand
K G
KG
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology*; D011379:Prognosis; D011956:Receptors, Cell Surface / Q000032:analysis* / Q000378:metabolism; D055293:Receptors, Urokinase Plasminogen Activator; D015996:Survival Rate; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis* / Q000378:metabolism
D014408:Biomarkers, Tumor; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator